121 related articles for article (PubMed ID: 3471282)
21. Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid.
Andreesen R; Munder PG
J Natl Cancer Inst; 1983 Apr; 70(4):623-7. PubMed ID: 6300501
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery.
Poloni A; Leoni P; Curzi L; Cantori I; Mancini S; Montanari M; Masia MC; Olivieri A
Exp Hematol; 1999 Oct; 27(10):1548-56. PubMed ID: 10517497
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
24. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
25. Short-term liquid marrow cultures are supported by a mixture of haematopoietic cytokines but do not purge for acute myeloid or lymphoid leukemic marrow cells.
Johnsen HE; Gaarsdal E; Jensen L; Philip P; Hansen NE
Leukemia; 1993 Sep; 7(9):1402-8. PubMed ID: 8371591
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
Singer CR; Linch DC
Leuk Res; 1987; 11(11):953-9. PubMed ID: 3320579
[TBL] [Abstract][Full Text] [Related]
27. Long-term bone marrow culture induces terminal differentiation of human myeloid leukemic cells.
Iland HJ; Croaker GM; Repka E; Radloff TJ; Vincent PC
Exp Hematol; 1987 Dec; 15(11):1109-14. PubMed ID: 3479335
[TBL] [Abstract][Full Text] [Related]
28. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
Douay L; Hu C; Giarratana MC; Bouchet S; Conlon J; Capizzi RL; Gorin NC
Blood; 1995 Oct; 86(7):2849-55. PubMed ID: 7670119
[TBL] [Abstract][Full Text] [Related]
29. Elimination of leukemic cells by the combined use of ether lipids in vitro.
Okamoto S; Olson AC; Vogler WR
Cancer Res; 1987 May; 47(10):2599-603. PubMed ID: 3471316
[TBL] [Abstract][Full Text] [Related]
30. Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin.
Casellas P; Canat X; Fauser AA; Gros O; Laurent G; Poncelet P; Jansen FK
Blood; 1985 Feb; 65(2):289-97. PubMed ID: 3871341
[TBL] [Abstract][Full Text] [Related]
31. Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent.
Scheffold C; Schöttker B; Lefterova P; Csipai M; Glasmacher A; Huhn D; Neubauer A; Schmidt-Wolf IG
Acta Haematol; 2000; 104(2-3):72-9. PubMed ID: 11154978
[TBL] [Abstract][Full Text] [Related]
32. Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.
el-Beltagi HM; Martens AC; Lelieveld P; Haroun EA; Hagenbeek A
Cancer Res; 1993 Jul; 53(13):3008-14. PubMed ID: 8319208
[TBL] [Abstract][Full Text] [Related]
33. Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow.
Vogler WR; Berdel WE
J Hematother; 1993; 2(1):93-102. PubMed ID: 7921970
[TBL] [Abstract][Full Text] [Related]
34. In vitro purging of clonogenic leukemic cells from human bone marrow by heat: simulation experiments for autologous bone marrow transplantation.
Moriyama Y; Hashimoto S; Goto T; Furukawa T; Kishi K; Takahashi M; Shibata A
Leuk Res; 1992 Oct; 16(10):973-7. PubMed ID: 1405711
[TBL] [Abstract][Full Text] [Related]
35. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
Calabretta B; Sims RB; Valtieri M; Caracciolo D; Szczylik C; Venturelli D; Ratajczak M; Beran M; Gewirtz AM
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2351-5. PubMed ID: 2006173
[TBL] [Abstract][Full Text] [Related]
36. Differences in heat sensitivity between normal and acute myeloid leukemic stem cells: feasibility of hyperthermic purging of leukemic cells from autologous stem cell grafts.
Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
Exp Hematol; 2003 May; 31(5):421-7. PubMed ID: 12763141
[TBL] [Abstract][Full Text] [Related]
37. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer.
Rill DR; Moen RC; Buschle M; Bartholomew C; Foreman NK; Mirro J; Krance RA; Ihle JN; Brenner MK
Blood; 1992 May; 79(10):2694-700. PubMed ID: 1316784
[TBL] [Abstract][Full Text] [Related]
38. No preferential sensitivity of clonogenic AML cells to ASTA-Z-7557.
Kluin-Nelemans HC; Martens AC; Löwenberg B; Hagenbeek A
Leuk Res; 1984; 8(4):723-8. PubMed ID: 6590937
[TBL] [Abstract][Full Text] [Related]
39. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells.
Dietzfelbinger HF; Lang A; Oberberg D; Rastetter JW; Berdel WE
Exp Hematol; 1992 Feb; 20(2):178-83. PubMed ID: 1544386
[TBL] [Abstract][Full Text] [Related]
40. Selective photosensitization of human leukemic cells by a pyrene-containing fatty acid.
Fibach E; Gatt S; Rachmilewitz EA
Exp Hematol; 1990 Feb; 18(2):89-93. PubMed ID: 2303106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
